Search results
Is Pfizer Stock a Millionaire Maker?
Motley Fool via Yahoo Finance· 3 months agoThe stock market is at record levels these days, but one company that isn't reflecting that optimism is Pfizer (NYSE: PFE). Shares of the pharma giant...
Market Today: CRISPR Therapeutics and Vertex Pharmaceuticals Make History with UK Drug Approval
GuruFocus.com via Yahoo Finance· 7 months agoThe gene editing sector experienced a significant shakeup as CRISPR Therapeutics (NASDAQ:CRSP) and...
Analyst unveils Amgen stock price target after weight-loss drug data
TheStreet via Yahoo Finance· 1 month agoIf Soranus of Ephesus were alive today he'd be mighty surprised. Like his modern-day counterparts in...
Intellia, Other CRISPR Stocks Hammered On Safety Concerns In New Gene-Editing Test
Investor's Business Daily· 2 years agoIntellia Therapeutics said early Friday it found a way to knock out the gene responsible for a rare...
Starbucks downgraded, Dollar Tree upgraded: Wall Street's top analyst calls
The Fly via Yahoo Finance· 1 month agoStarbucks downgraded, Dollar Tree upgraded: Wall Street's top analyst calls The most talked about...
Why Pfizer Likely Isn't Done With M&A After the Seagen Deal
Motley Fool· 1 year agoPfizer (NYSE: PFE) has been a company on a mission, looking to restock its pipeline with growth...
Insmed stocks soar as Phase III lung disease drug exceeds expectations
Clinical Trials Arena via Yahoo Finance· 1 week agoInsmed’s stocks more than doubled after the company announced its lead-pipeline candidate...
3 No-Brainer Stocks You Can Buy Right Now
Motley Fool· 11 months agoHere's why they think AbbVie (NYSE: ABBV), Pfizer (NYSE: PFE), and Vertex Pharmaceuticals (NASDAQ: VRTX) are no-brainer stocks to buy right now. Prosper...
Pfizer's (PFE) Ulcerative Colitis Pill Velsipity Gets EU Nod
Zacks via Yahoo Finance· 4 months agoPfizer PFE announced that the European Commission has granted marketing approval to its oral,...
Did Amazon Just Say "Checkmate" to Nvidia?
The Motley Fool via AOL· 6 days agoMuch of the ongoing discussion on artificial intelligence (AI) revolves around the "Magnificent Seven" stocks. Over the past 18 months, big tech has made...